PRESS RELEASES

To receive all future Arrow press releases please click here (link to subscription form – name, company, job title, email address - which gets emailed to Annie)

Recent Press Releases

6th February 2006 - Arrow Therapeutics selects Hepatitis C clinical candidate
Arrow has announced that its lead Hepatitis C compound has entered full preclinical development.
Originating from Arrow’s focused chemical library and optimised in-house, the compound (A-831) has shown potent activity in the replicon assay and has an excellent therapeutic index and good pharmacokinetic properties, as well as displaying a novel mechanism of action targeting the NS5a protein. Phase I trials on the compound are planned for the second half of 2006, by which time a further compound from Arrow’s second Hepatitis C programme (also targeting the NS5a protein) is expected to enter preclinical development.
(paragraph above as link to full press release)

Press Release Archive (all with link to press release list for that year and further link to each press release on the list – individual press releases to be provided by Annie)

2005
2004
2003
2002
2001
2000
1999
1998

PRODUCT PIPELINE